T
Tilda Research Inc. | HQ, Irvine, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
LY3009104
Baricitinib
PF-04965842
LBP-EC01
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
This study is designed to select up to two doses of baricitinib (referred to as low dose and high dose) and assess their efficacy and safety for the...
Active, not recruiting
Alopecia Areata
Drug: Baricitinib
Drug: Placebo
To evaluate the safety and efficacy of implanting pellet-type extracellular matrix-associated autologous chondrocytes (CartiLife®) obtained by cultiv...
Enrolling
Articular Cartilage Degeneration
Articular Cartilage Defect
Drug: Autologous Chondrocyte Implantation (CartiLife®)
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg
Trial sponsors
B
L
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems